No connection

Search Results

HIT vs LGCL

HIT
Health In Tech, Inc.
BEARISH
Price
$1.34
Market Cap
$87.8M
Sector
Technology
AI Confidence
85%
LGCL
Lucas GC Limited
BEARISH
Price
$1.90
Market Cap
$81.3M
Sector
Technology
AI Confidence
90%

Valuation

P/E Ratio
HIT
67.0
LGCL
--
Forward P/E
HIT
7.24
LGCL
--
P/B Ratio
HIT
4.51
LGCL
0.11
P/S Ratio
HIT
2.64
LGCL
0.1
EV/EBITDA
HIT
29.98
LGCL
89.62

Profitability

Gross Margin
HIT
62.82%
LGCL
33.72%
Operating Margin
HIT
-2.27%
LGCL
3.95%
Profit Margin
HIT
3.84%
LGCL
0.9%
ROE
HIT
8.45%
LGCL
2.52%
ROA
HIT
4.92%
LGCL
-1.41%

Growth

Revenue Growth
HIT
53.1%
LGCL
-36.1%
Earnings Growth
HIT
--
LGCL
-61.5%

Financial Health

Debt/Equity
HIT
0.01
LGCL
0.28
Current Ratio
HIT
3.13
LGCL
1.88
Quick Ratio
HIT
2.31
LGCL
0.6

Dividends

Dividend Yield
HIT
--
LGCL
--
Payout Ratio
HIT
0.0%
LGCL
0.0%

AI Verdict

HIT BEARISH

HIT presents a high-risk profile characterized by a Piotroski F-Score of 4/9 (Stable) but severe technical deterioration. While the company exhibits strong revenue growth (53.10%) and an exceptionally clean balance sheet (Debt/Equity 0.01), it is trading at a massive premium to its Graham Number ($0.37) and Intrinsic Value ($0.14). The stock is currently in a freefall with a 0/100 technical trend and a 60.8% decline over the last six months, coupled with a poor earnings track record of 0/4 beats.

Strengths
Strong YoY and Q/Q revenue growth of ~53%
Negligible debt levels (Debt/Equity 0.01)
Robust liquidity with a Current Ratio of 3.13
Risks
Severe bearish technical trend (0/100 score)
Significant overvaluation relative to Graham and Intrinsic values
Negative operating margin (-2.28%) indicating operational inefficiency
LGCL BEARISH

LGCL presents as a classic value trap, characterized by a stable Piotroski F-Score of 5/9 but offset by catastrophic growth and price performance. While the stock trades at an extreme discount to book value (P/B 0.11) and sales (P/S 0.10), these metrics are overshadowed by a -36.10% YoY revenue decline and a -61.50% collapse in earnings. The massive price drop from a 52-week high of $50.80 to $1.90 indicates a total loss of investor confidence, and the recent short-term bounce appears speculative rather than fundamental.

Strengths
Extremely low Price-to-Book ratio (0.11)
Low Debt-to-Equity ratio (0.28)
Healthy Current Ratio (1.88) indicating short-term liquidity
Risks
Severe revenue contraction (-36.10% YoY)
Rapidly declining earnings (-61.50% YoY)
Catastrophic long-term price performance (-98.7% over 5 years)

Compare Another Pair

HIT vs LGCL: Head-to-Head Comparison

This page compares Health In Tech, Inc. (HIT) and Lucas GC Limited (LGCL) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.

Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.

Home
Terminal
AI
Markets
Profile